A detailed history of Baader Bank Aktiengesellschaft transactions in Mannkind Corp stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 42,118 shares of MNKD stock, worth $295,668. This represents 0.02% of its overall portfolio holdings.

Number of Shares
42,118
Holding current value
$295,668
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$5.01 - $6.7 $211,011 - $282,190
42,118 New
42,118 $264,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Baader Bank Aktiengesellschaft Portfolio

Follow Baader Bank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.